Parenchymal Hemorrhagic Demyelination (PHD)

Parenchymal hemorrhagic demyelination (PHD) is a mouth-ful of medical jargon that simply means “bleeding inside brain tissue that is also losing its insulating myelin coating.” Myelin is the fatty sheath that lets nerve signals travel quickly; demyelination strips that sheath away, while hemorrhage adds blood and breakdown products that irritate and swell the tissue. The best-known catastrophic example is acute hemorrhagic leukoencephalitis (AHLE), or Weston-Hurst disease, an explosive post-infectious variant of acute disseminated encephalomyelitis (ADEM) where white-matter inflammation, small-vessel injury, and pinpoint hemorrhages appear together radiopaedia.org. Although PHD is rare, it illustrates how inflammation, immunity, and micro-vascular fragility can collide and cause sudden neurological disaster.

---

Pathophysiology

1. Trigger – A virus, vaccine, toxin, autoimmune flare, trauma, or severe drop in oxygen may irritate the brain’s immune cells.

2. Immune storm – Microglia and infiltrating lymphocytes fire inflammatory chemicals (cytokines) meant to fight infection but which also attack myelin proteins.

3. Capillary breakdown – Inflammation loosens the “tight junctions” between small blood-vessel cells, making capillaries leaky. Red blood cells ooze out, creating petechiae (tiny dots of blood) throughout white matter.

4. Myelin loss – Oligodendrocytes (the cells that make myelin) die or fall silent; the naked axons conduct signals poorly and are prone to secondary damage.

5. Edema and pressure – Fluid, blood, and immune cells swell the tissue, raising intracranial pressure and squeezing neighboring structures.

6. Secondary neuronal injury – Iron from hemoglobin catalyzes free-radical reactions; excitotoxic glutamate and cytokines injure nearby neurons, making the clinical picture worse.

---

Types of parenchymal hemorrhagic demyelination

Because PHD is a descriptive, not a single-disease label, clinicians group it by context:

1. Fulminant post-infectious type (AHLE/AHEM) – explosive, often after a viral or bacterial illness, sometimes fatal within days pmc.ncbi.nlm.nih.gov.

2. Necrotizing demyelination secondary to vasculitis – autoimmune small-vessel inflammation (e.g., Behçet disease, ANCA-associated vasculitis) with patchy hemorrhage.

3. Tumefactive hemorrhagic demyelinating lesion – looks like a brain tumor on MRI; may occur in relapsing–remitting or aggressive multiple sclerosis cjns.gums.ac.ir.

4. Hypoxic-ischemic hemorrhagic demyelination – seen after severe cardiac arrest or carbon-monoxide poisoning where reperfusion injures capillaries.

5. Iatrogenic/toxic hemorrhagic demyelination – following high-dose radiation, methotrexate, immune-checkpoint inhibitors, or illicit inhalants (“chasing the dragon”).

---

Causes

1. Post-viral immune reaction (e.g., influenza, measles, SARS-CoV-2) – A few days to weeks after the fever breaks, antibodies intended for the virus cross-react with myelin basic protein, launching an outsized attack that includes vessel injury and pinpoint bleeds.

2. Post-bacterial illness (Mycoplasma pneumoniae, Streptococcus) – Similar molecular mimicry drives a hyper-acute demyelinating storm with small hemorrhages.

3. Live or attenuated vaccine response – Very rarely, antigenic triggers in vaccines spark AHLE-like demyelination; modern surveillance makes it exceptional.

4. Classic acute disseminated encephalomyelitis (ADEM) tipping into hemorrhage – When inflammation is so intense that capillary walls rupture, ADEM morphs into its hemorrhagic form.

5. Multiple-sclerosis tumefactive relapse – A solitary, large MS plaque swells, undergoes necrosis and capillary injury, and bleeds internally.

6. Cerebral vasculitis (primary angiitis of the CNS, lupus cerebritis) – Inflamed vessels scorch white matter, strip myelin, and leak blood.

7. Behçet disease – Neutrophilic vasculitis predisposes to hemorrhagic necrosis in deep structures such as the brainstem.

8. Antineutrophil cytoplasmic antibody (ANCA) vasculitis – Small-vessel granulomas cut oxygen to myelin and cause vessel rupture.

9. Antiphospholipid antibody syndrome – Hyper-coagulability alternates with vessel wall inflammation, producing hemorrhagic–ischemic demyelination.

10. Herpes simplex encephalitis overlapping demyelination – Direct viral cytotoxicity plus immune-mediated stripping yields mixed necrotizing hemorrhage and demyelination.

11. West Nile or Japanese encephalitis – Vasculotropic flaviviruses that damage endothelial cells and myelin simultaneously.

12. Hypoxic-ischemic injury after cardiac arrest – Reperfusion floods fragile capillaries in already myelin-vulnerable white matter.

13. High-altitude cerebral edema – Hypoxia, vascular leakage, and inflammatory mediators can cause scattered hemorrhagic demyelinating foci.

14. Radiation necrosis (brain tumor treatment) – Months to years later, irradiated tissue loses oligodendrocytes; fragile neo-vasculature bleeds into the demyelinating zone.

15. High-dose methotrexate or cytarabine toxicity – Direct oligodendrocyte and endothelial injury results in combined demyelination and micro-bleeds.

16. Immune-checkpoint inhibitor (e.g., nivolumab) neurotoxicity – Potent T-cell activation occasionally attacks CNS myelin and capillaries.

17. Mitochondrial cytopathy (e.g., Leigh syndrome) with vascular mito-angiopathy – Energy failure damages both myelin maintenance and vascular integrity.

18. Central pontine myelinolysis with hemorrhagic conversion – Rapid correction of severe hyponatremia cracks endothelium as well as myelin.

19. Inhalation of heroin fumes (“leukoencephalopathy from chasing the dragon”) – Toxic lipids and heat injure oligodendrocytes; edema and hemorrhage follow.

20. Severe traumatic axonal injury – Shearing forces rip myelin and tear micro-vessels, scattering petechial hemorrhages through white tracts.

---

Common symptoms and warning signs

1. Thunderclap headache – Sudden, intense pain from pressure as blood and fluid accumulate.

2. Rapidly worsening drowsiness – Swollen tissue raises intracranial pressure, depressing alertness.

3. Seizures – Blood products irritate the cortex; demyelination short-circuits normal electrical pathways.

4. High fever or recent infection history – Clue to post-infectious immune activation.

5. Neck stiffness or photophobia – Meningeal irritation from adjacent inflammation.

6. Confusion and disorientation – White-matter tract failure disconnects cortical hubs.

7. Focal weakness (hemiparesis) – Damage to corticospinal fibers interrupts motor signals.

8. Loss of coordination (ataxia) – Cerebellar or cerebellar-fiber involvement throws balance off.

9. Slurred speech (dysarthria) – Brain-stem demyelination affects cranial-nerve nuclei and articulatory tracts.

10. Double vision (diplopia) – Pontine or midbrain involvement disturbs ocular-motor pathways.

11. Numbness or tingling – Sensory tract demyelination misfires or silences signals.

12. Loss of bladder control – Disrupted descending autonomic fibers in the spinal cord or brain stem.

13. Visual blurring or field loss – Optic radiation or occipital involvement plus edema.

14. Sudden personality change – Frontal white-matter hemorrhagic demyelination alters executive and emotional circuits.

15. Intractable vomiting – Area postrema involvement or raised intracranial pressure.

16. Gait freezing or leg dragging – Wide-spread conduction block in long descending tracts.

17. Vertigo – Vestibular pathway damage within brain stem white matter.

18. Hearing loss or tinnitus – Hemorrhagic demyelination near the auditory pathway.

19. Respiratory irregularity – Medullary centers compressed by swelling.

20. Coma – Extensive bilateral involvement with mass effect on the reticular activating system.

---

Diagnostic tests

A. Physical examination

1. Level-of-consciousness assessment (Glasgow Coma Scale) – A quick bedside score tells how deeply the brain is depressed. Falling numbers signal expanding hemorrhage.

2. Vital-sign pattern check (Cushing triad) – Rising blood pressure, slowing pulse, and irregular breathing warn of dangerous intracranial pressure.

3. Fundoscopic exam for papilledema – Swollen optic-disc margins imply raised pressure from edema and bleeding.

4. Pupillary light reflexes – Asymmetric or sluggish pupils hint at brain-stem compression.

5. Motor-strength grading – Detects new weakness mapped to white-matter tracts.

6. Sensory-modality testing (light-touch, pin-prick, vibration) – Patchy deficits suggest scattered demyelinating foci.

7. Cerebellar finger-nose and heel-shin maneuvers – Discoordination reveals cerebellar tract injury.

8. Gait observation – Wide-based or spastic gait points toward white-matter disconnection.

B. Manual or bedside functional tests

9. Babinski sign elicitation – An up-going toe means corticospinal tract breakdown.

10. Romberg balance test – Swaying with eyes closed denotes proprioceptive pathway failure in demyelinated columns.

11. Oculocephalic (doll’s-eyes) reflex – Absent response suggests brain-stem involvement.

12. Pronator drift test – Subtle corticospinal weakness appears as arm drifting and pronation.

13. Rapid-alternating-movement (diadochokinesis) – Clumsiness indicates cerebellar-cortical disconnection.

14. Visual field confrontation – Detects optic-radiation or occipital lobe lesions hidden from the patient.

15. Mini-Mental State Examination (MMSE) – Quick cognitive screening identifies white-matter executive dysfunction.

C. Laboratory & pathological tests

16. Complete blood count (CBC) – High white-cell count may support infection or severe inflammation.

17. C-reactive protein & ESR – Elevated markers back an inflammatory etiology.

18. Serum electrolytes & osmolarity – Rules out rapid sodium shifts that provoke osmotic demyelination.

19. Autoimmune antibody panel (ANA, ANCA, antiphospholipid) – Searches for vasculitic or autoimmune triggers.

20. Viral PCR on blood and CSF (e.g., HSV, influenza, SARS-CoV-2) – Looks for recent or ongoing infection.

21. Lumbar puncture for CSF analysis – Shows high protein, lymphocytic pleocytosis, and — importantly — xanthochromia or red cells pointing to hemorrhage.

22. Oligoclonal bands in CSF – Reveal intrathecal antibody production common in demyelinating disorders.

23. Myelin basic-protein level in CSF – Direct marker of myelin breakdown.

24. Coagulation profile (PT, aPTT, INR, D-dimer) – Detects coagulopathies that could provoke micro-bleeds.

25. Brain-biopsy histopathology – Gold-standard proof: luxol-fast-blue loss of myelin, perivascular hemorrhage, macrophage-filled with myelin debris pmc.ncbi.nlm.nih.gov.

26. Immunohistochemistry for T-cells and complement – Confirms immune-mediated vascular injury.

D. Electrodiagnostic tests

27. Visual-evoked potentials (VEP) – Delayed conduction latency shows demyelination along optic pathways—even if MRI is equivocal.

28. Brain-stem auditory-evoked responses (BAER) – Prolonged waves indicate brain-stem white-matter injury with possible micro-hemorrhage.

29. Somatosensory-evoked potentials (SSEP) – Track ascending sensory pathway slowdown from demyelination.

30. Continuous EEG monitoring – Detects subclinical seizures or symmetric slowing from diffuse hemorrhagic demyelination.

E. Imaging studies

31. Non-contrast CT head – Fast bedside scan reveals hyperdense foci of acute blood plus patchy low-density edema.

32. MRI T2/FLAIR – Shows bright demyelinated lesions with dark blooming susceptibility signals (micro-bleeds).

33. MRI susceptibility-weighted imaging (SWI) – Highly sensitive for petechial hemorrhages peppering white matter.

34. MRI diffusion-weighted imaging (DWI) – Diffusion restriction marks cytotoxic edema and necrosis in fulminant lesions.

35. MRI post-contrast T1 – “Open-ring” or “incomplete-ring” enhancement suggests tumefactive demyelination rather than abscess or tumor.

36. Magnetic-resonance venography (MRV) – Excludes venous thrombosis that can mimic or compound hemorrhagic lesions.

37. MR perfusion and spectroscopy – Low cerebral blood volume and elevated choline support demyelination over neoplasm.

38. Digital-subtraction angiography (DSA) – Maps vasculitis or vascular malformations that precipitate hemorrhage.

39. Positron-emission tomography (FDG-PET) – Hypometabolism in demyelinating zones helps differentiate from high-grade tumors that over-consume glucose.

40. Serial imaging follow-up – Re-scanning at 24- to 72-hour intervals tracks expansion or resolution under steroids, guiding ICU decisions.

Non-Pharmacological Treatments

Below are fully described, plain-language interventions. Each paragraph gives what it is, why it’s used, and how it works.

Physiotherapy & Electrotherapy

1. Passive range-of-motion (PROM) – Therapists gently move paralysed limbs several times a day to stop contractures, stimulate proprioceptors, and preserve joint nutrition; early motion also reduces heterotopic ossification risk. pmc.ncbi.nlm.nih.gov

2. Active-assisted movement – Once minimal voluntary activity returns, elastic bands or robotic gloves help patients finish each movement, reinforcing cortical re-mapping.

3. Progressive resistive strengthening – Graduated weights strengthen anti-gravity muscles, counter steroid-induced myopathy, and enhance neuroplastic drive.

4. Body-weight–supported treadmill gait training – Harness unloads up to 40 % body weight, allowing safe early stepping; rhythmic sensory input entrains central pattern generators for locomotion.

5. Functional electrical stimulation (FES) – Surface electrodes fire ankle-dorsiflexors during swing phase, preventing foot-drop and enhancing cortical-spinal tract connectivity.

6. Transcranial magnetic stimulation (rTMS) – High-frequency pulses to ipsilesional M1 raise excitability and may accelerate motor recovery by modulating synaptic plasticity.

7. Transcutaneous electrical nerve stimulation (TENS) – Low-voltage currents applied to dermatomes reduce neuropathic pain via the gate-control mechanism.

8. Interferential therapy – Crossing medium-frequency currents produce a low-frequency beat deep in tissues, improving local blood flow and edema resorption.

9. Hydrotherapy – Warm-water buoyancy unloads joints and provides gentle resistance, easing spasticity and allowing near-normal movement patterns.

10. Constraint-induced movement therapy (CIMT) – Unaffected limb is splinted to force use of the weaker side, strengthening synapses in motor cortex.

11. Balance platform training – Computerised force plates give instant biofeedback on sway, retraining vestibulo-spinal reflexes and cerebellar circuits.

12. Vestibular rehabilitation – Canalith repositioning and gaze-stability drills reduce diplopia and dizziness from brain-stem lesions.

13. Respiratory physiotherapy – Incentive spirometry plus manually-assisted cough prevent atelectasis and pneumonia during bedridden phases.

14. Proprioceptive neuromuscular facilitation (PNF) patterns – Spiral-diagonal limb movements recruit entire synergy chains, promoting functional carry-over.

15. Infra-red photobiomodulation – Near-infra-red light applied over cervical cord may boost mitochondrial cytochrome-c oxidase, supporting neuronal survival (early experimental stage).

Exercise programmes

16. Interval cycling – Short bursts at 70 % VO₂max followed by rest improve fatigue and aerobic capacity without prolonged core-temperature rise that can worsen demyelination. pmc.ncbi.nlm.nih.gov

17. Pilates-based core routine – Low-impact mat work reinforces deep stabilisers, lessening axial rigidity and low-back pain.

18. Swimming with adaptive snorkel – Provides full-body workout while cool water blunts Uhthoff’s heat-sensitivity.

19. Nordic walking – Poles offload knee joints, engage upper body, and raise metabolic equivalents safely.

20. Thera-band shoulder circuit – Colour-coded bands allow graded resistance to maintain scapular control important for wheelchair propulsion.

Mind-body therapies

21. Mindfulness-based stress reduction (MBSR) – Eight-week course trains focused attention; fMRI shows reduced amygdala reactivity and improved fatigue scores in MS trials. pmc.ncbi.nlm.nih.gov

22. Gentle hatha yoga – Combines asanas, pranayama, and relaxation; lowers cortisol and improves balance.

23. Guided imagery – Audio scripts lead patients through restorative visual scenes, engaging parasympathetic pathways and dampening pain circuits.

24. Biofeedback for pelvic floor – Surface EMG teaches volitional control of sphincters, reducing neurogenic bladder accidents.

25. Autogenic training – Self-suggested warmth/heaviness phrases recalibrate autonomic tone, easing spasticity.

Educational / self-management strategies

26. Fatigue diary & energy banking – Patients log activities, then prioritise essential tasks and schedule rests before exhaustion sets in. pmc.ncbi.nlm.nih.gov

27. SMART goal-setting workshops – Break rehabilitation into Specific, Measurable, Achievable, Relevant, Time-bound milestones, sustaining motivation.

28. Teach-back medication coaching – Nurses ask patients to repeat dosing instructions, catching misunderstandings early.

29. Peer-led support groups – Sharing lived experience reduces isolation and improves adherence.

30. Tele-rehab portals – Secure video sessions maintain therapy intensity when travel is impossible.

---

Evidence-Based Drugs

(Usual adult dosing is illustrative; always individualise and monitor in a specialised centre).

---

Dietary Molecular Supplements

1. Vitamin D₃ 4 000 IU daily – Boosts regulatory T-cells, lowers relapse rate in demyelinating disease; monitor Ca²⁺. pmc.ncbi.nlm.nih.gov

2. Omega-3 (EPA + DHA 2 g) – Competes with arachidonic acid, dampening neuro-inflammation and supporting myelin lipid synthesis.

3. Curcumin 1 g BID with black pepper – Inhibits NF-κB and oxidative stress, shown to reduce MS fatigue scores.

4. Alpha-lipoic acid 600 mg/day – Chelates iron, crosses BBB, and cuts MMP-9 activity.

5. Resveratrol 150 mg/day – Activates SIRT-1, promoting mitochondrial resilience.

6. N-acetyl-cysteine 600 mg BID – Replenishes glutathione, limiting free-radical-mediated myelin damage.

7. High-biotin (MD1003) 300 mg/day – Co-factor for acetyl-CoA-carboxylase, may up-regulate myelin lipid synthesis in progressive MS.

8. Probiotic mix ≥10⁹ CFU/day – Modulates gut-brain axis, lowering systemic IL-17.

9. Cod-liver oil 1 tbsp (provides A, D, EPA/DHA) – Small observational data link adolescent intake to lower MS risk. verywellhealth.com

10. Coenzyme Q10 200 mg/day – Revs neuronal ATP production, easing fatigue.

---

Specialised Drugs (Bisphosphonate, Regenerative, Viscosupplement, Stem-cell)

1. Zoledronic acid 5 mg IV yearly – Nitrogen bisphosphonate; blocks farnesyl-pyrophosphate synthase, indirectly reduces microglial prenylation and neuro-inflammation; use mainly when osteoporosis co-exists. pubmed.ncbi.nlm.nih.gov

2. Alendronate 70 mg PO weekly – Same class; oral route for bone loss on chronic steroids, potential cognitive benefits under study.

3. Hyaluronic acid viscosupplement 20 mg intra-articular (e.g., knee) – Though joint-targeted, relieving co-morbid osteoarthritis improves overall mobility and rehab tolerance. pmc.ncbi.nlm.nih.gov

4. Platelet-rich plasma (PRP) 5 mL intra-articular) – Concentrated autologous growth factors enhance periarticular repair, indirectly boosting gait practice.

5. Opicinumab 100 mg/kg IV q4w (anti-LINGO-1) – Experimental antibody aiming to unblock oligodendrocyte maturation and remyelination.

6. Clemastine fumarate 5.34 mg PO BID – Histamine H₁ blocker repurposed; phase-II showed shortened optic-nerve conduction latency, indicating remyelination.

7. High-dose Biotin (MD1003) – Already listed above, doubles as regenerative drug.

8. Siponimod 2 mg PO daily – Second-generation S1P modulator with evidence of slowing brain atrophy; supports endogenous repair.

9. Intrathecal MSC-NPs (6 × injections every 2 months) – Autologous mesenchymal stem cell-derived neural progenitors; phase-II data show walking-speed gains in progressive MS subgroup. stemcellres.biomedcentral.com

10. Autologous HSCT (cyclophosphamide + ATG conditioning) – “Resets” immune repertoire; durable remission reported in aggressive demyelination but carries transplant risks.

---

Surgical Options

1. Decompressive craniectomy – Removes a large skull flap to give swollen hemispheres room, preventing herniation; life-saving within first 24 h of uncontrolled ICP. pmc.ncbi.nlm.nih.govfrontiersin.org

2. External ventricular drain (EVD) – Drains CSF and monitors ICP continuously.

3. Endoscopic hematoma evacuation – Minimally invasive suction of large lobar bleed reducing mass effect.

4. Stereotactic brain biopsy – Obtains diagnostic tissue when imaging is equivocal, guiding immunotherapy.

5. Duraplasty – Expands constrained dura mater during decompression, further lowering ICP.

6. Intracranial pressure monitor bolt – Real-time monitoring to titrate osmotherapy and ventilation.

7. Ventriculoperitoneal shunt – Long-term CSF diversion if hydrocephalus ensues.

8. Spinal cord decompression – Rare but indicated if hemorrhagic plaques in cervical cord threaten breathing.

9. Neuro-endoscopic third ventriculostomy – Alternative CSF pathway if aqueductal blockage develops.

10. Selective tendon-lengthening – Later stage; releases fixed contractures that resist physiotherapy, enhancing mobility.

---

Prevention Strategies

1. Prompt treatment of upper-respiratory infections with antivirals/antibiotics when appropriate.

2. Seasonal influenza and pneumococcal vaccination to curb common triggers.

3. Strict peri-operative infection control in immunosuppressed patients.

4. Vitamin D sufficiency (serum 25-OHD > 50 nmol/L).

5. Healthy body-weight & exercise to reduce systemic inflammation.

6. Smoking cessation – smoking triples demyelination relapse risk.

7. Protective headgear during high-impact sports to minimise traumatic co-bleeds.

8. Early blood-pressure control; hypertension exacerbates microvascular rupture.

9. Regular dental care – reduces chronic low-grade bacteremia that can incite auto-immunity.

10. Stress-management programmes – high cortisol spikes precede many autoimmune flares.

---

When should you see a doctor urgently?

Any sudden neurological change—new seizure, loss of speech, unilateral weakness, severe headache with vomiting, vision blackout, or rapidly worsening drowsiness—demands emergency imaging and specialist review within one hour. Delayed care dramatically increases death or severe disability because hemorrhage and edema expand quickly. pmc.ncbi.nlm.nih.gov

---

“Do’s & Don’ts”

Do:

1. Keep vaccinations up-to-date.

2. Adhere strictly to steroid taper schedules.

3. Use cooling vests during hot weather exercise.

4. Maintain a symptom diary.

5. Engage in guided relaxation daily.

Don’t:
6. Skip prescribed gastro-protection when on steroids.
7. Ignore subtle vision or speech changes.
8. Self-medicate with high-dose aspirin (risk of worsening bleed).
9. Take herbal immunostimulants without medical advice (may provoke relapse).
10. Drive until seizure-free and cleared by a neurologist.

Mortality has fallen from >70 % to near 40 % with rapid imaging, high-dose steroids, and timely decompressive surgery. Survivors often regain independence (median modified Rankin Score ≤ 2) when aggressive multidisciplinary rehab begins in the first week. pmc.ncbi.nlm.nih.gov

---

Frequently Asked Questions

1. Is PHD the same as multiple sclerosis? – No; it is an explosive, often one-off hyper-acute variant, whereas MS is typically relapsing-remitting.

2. Can COVID-19 cause it? – A handful of confirmed AHLE cases followed severe COVID-19; vigilance is warranted. pmc.ncbi.nlm.nih.gov

3. Will every bleed need surgery? – Only uncontrolled ICP or large lobar bleeds; most managed medically.

4. Are steroids always first? – Yes; they remain the cornerstone to halt immune attack and edema.

5. How long is rehab? – Intensive phase 3–6 months; neurological recovery can continue for two years.

6. Can children get PHD? – Yes though rarer; outcomes improve with early plasma-exchange.

7. Is it contagious? – No; only the antecedent infection may be.

8. Will I need lifelong drugs? – Not always; some taper off after six months if stable.

9. Can diet alone cure it? – No; dietary measures are supportive, not curative.

10. What about pregnancy? – Plan conception only after six months of stability; some immunotherapies are teratogenic.

11. Is MRI with contrast safe post-bleed? – Usually after 48 h when renal function allows gadolinium clearance.

12. Why do I feel extreme fatigue? – Neuro-inflammatory cytokines and deconditioning; graded exercise plus sleep hygiene helps.

13. Will my memory return? – Cognitive rehab plus neural plasticity often restore much function over months.

14. Can stem-cells make me walk again? – Early trials are promising but not yet standard; discuss within clinical-trial frameworks.

15. How do I explain this to family? – “My immune system briefly attacked my brain’s wiring and some small vessels bled; doctors stopped the attack and now rehab is rewiring my circuits.”

 

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: July 01, 2025.